<DOC>
	<DOCNO>NCT00189007</DOCNO>
	<brief_summary>A former study ( submit ) 32 severely asphyxiated infant participate randomize double blind study , early postnatal allopurinol placebo ( within 4 hour birth ) administer reduce free radical formation consequently reperfusion/reoxygenation injury newborn brain , show unaltered high mortality clinically relevant improvement morbidity infant treat allopurinol . It hypothesize postnatal allopurinol treatment start late reduce reperfusion-induced free radical surge initiate allopurinol treatment fetus ( imminent ) hypoxia already via mother labor effective reduce free radical-induced post-asphyxial brain damage .</brief_summary>
	<brief_title>Antenatal Allopurinol During Fetal Hypoxia</brief_title>
	<detailed_description />
	<mesh_term>Anoxia</mesh_term>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Fetal Hypoxia</mesh_term>
	<mesh_term>Mannitol</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<criteria>Gestational age 36 week Nonreassuring CTG , significant event STANmonitor AND/OR FBS &lt; 7.20 Chromosomal abnormality</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>allopurinol</keyword>
	<keyword>neuroprotection</keyword>
	<keyword>reperfusion injury</keyword>
	<keyword>fetal hypoxia</keyword>
	<keyword>post hypoxic-ischemic reperfusion damage</keyword>
</DOC>